dc.contributor.author | Hartkopf, Andreas | |
dc.date.accessioned | 2021-11-22T09:34:30Z | |
dc.date.available | 2021-11-22T09:34:30Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1879-0852 | |
dc.identifier.uri | http://hdl.handle.net/10900/120915 | |
dc.language.iso | en | de_DE |
dc.publisher | Elsevier Sci Ltd | de_DE |
dc.relation.uri | http://dx.doi.org/10.1016/j.ejca.2021.03.045 | de_DE |
dc.subject.ddc | 610 | de_DE |
dc.title | Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study | de_DE |
dc.type | Article | de_DE |
utue.quellen.id | 20210824232002_01021 | |
utue.publikation.seiten | 268-277 | de_DE |
utue.personen.roh | Lueftner, Diana | |
utue.personen.roh | Tesch, Hans | |
utue.personen.roh | Schmidt, Marcus | |
utue.personen.roh | Hartkopf, Andreas D. | |
utue.personen.roh | Streicher, Sarah | |
utue.personen.roh | Resch, Anna | |
utue.personen.roh | Genovese, Luca | |
utue.personen.roh | Rose, Christian | |
utue.personen.roh | Valenti, Roberta | |
utue.personen.roh | Harbeck, Nadia | |
dcterms.isPartOf.ZSTitelID | European Journal of Cancer | de_DE |
dcterms.isPartOf.ZS-Volume | 150 | de_DE |
utue.fakultaet | 04 Medizinische Fakultät | de_DE |
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |